This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2002 May 15;165(10):1353-8.

doi: 10.1164/rccm.2109060.

Beta-agonist intrinsic efficacy: measurement and clinical significance

Nicola A Hanania¹, Amir Sharafkhaneh, Roger Barber, Burton F Dickey

Affiliations

Affiliation

¹ Section of Pulmonary and Critical Care Medicine, Department of Medicine, Baylor College of Medicine and the Houston Veterans Administration Medical Center, Texas 77030, USA. Hanania@bcm.tmc.edu

PMID: 12016095
DOI: 10.1164/rccm.2109060

Review

Beta-agonist intrinsic efficacy: measurement and clinical significance

Nicola A Hanania et al. Am J Respir Crit Care Med. 2002.

. 2002 May 15;165(10):1353-8.

doi: 10.1164/rccm.2109060.

Authors

Nicola A Hanania¹, Amir Sharafkhaneh, Roger Barber, Burton F Dickey

Affiliation

¹ Section of Pulmonary and Critical Care Medicine, Department of Medicine, Baylor College of Medicine and the Houston Veterans Administration Medical Center, Texas 77030, USA. Hanania@bcm.tmc.edu

PMID: 12016095
DOI: 10.1164/rccm.2109060

No abstract available

PubMed Disclaimer

Similar articles

[Efficacy and safety of indacaterol - new long-acting beta(2) agonist].
Chazan R. Chazan R. Pneumonol Alergol Pol. 2010;78(3):229-35. Pneumonol Alergol Pol. 2010. PMID: 20461692 Review. Polish.
[Asthma overmortality under beta-2-mimetics. Does it depend on the drug itself or on false use].
Petro W. Petro W. MMW Fortschr Med. 2005 Mar 10;147(10):16. MMW Fortschr Med. 2005. PMID: 15803777 German. No abstract available.
Indacaterol Novartis/skyePharma.
Currie GP. Currie GP. Curr Opin Investig Drugs. 2006 May;7(5):457-63. Curr Opin Investig Drugs. 2006. PMID: 16729723
Risk versus benefit considerations for the beta(2)-agonists.
Kelly HW. Kelly HW. Pharmacotherapy. 2006 Sep;26(9 Pt 2):164S-74S. doi: 10.1592/phco.26.9part2.164S. Pharmacotherapy. 2006. PMID: 16945063
[Clinical effectiveness of synergic therapy].
Płusa T, Lubiński W. Płusa T, et al. Pol Merkur Lekarski. 2004 May;16 Suppl 1:20-2. Pol Merkur Lekarski. 2004. PMID: 15524008 Review. Polish.

See all similar articles

Cited by

Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.
Lee DK, Jackson CM, Bates CE, Lipworth BJ. Lee DK, et al. Thorax. 2004 Aug;59(8):662-7. doi: 10.1136/thx.2003.019059. Thorax. 2004. PMID: 15282385 Free PMC article. Clinical Trial.
Regulation of mast cells by beta-agonists.
Peachell P. Peachell P. Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):131-42. doi: 10.1385/CRIAI:31:2:131. Clin Rev Allergy Immunol. 2006. PMID: 17085789 Review.
ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?
Matera MG, Cazzola M. Matera MG, et al. Drugs. 2007;67(4):503-15. doi: 10.2165/00003495-200767040-00002. Drugs. 2007. PMID: 17352511 Review.
Inhaled steroids with and without regular salmeterol for asthma: serious adverse events.
Cates CJ, Schmidt S, Ferrer M, Sayer B, Waterson S. Cates CJ, et al. Cochrane Database Syst Rev. 2018 Dec 3;12(12):CD006922. doi: 10.1002/14651858.CD006922.pub4. Cochrane Database Syst Rev. 2018. PMID: 30521673 Free PMC article.
Regular treatment with salmeterol for chronic asthma: serious adverse events.
Cates CJ, Cates MJ. Cates CJ, et al. Cochrane Database Syst Rev. 2008 Jul 16;2008(3):CD006363. doi: 10.1002/14651858.CD006363.pub2. Cochrane Database Syst Rev. 2008. PMID: 18646149 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information